Evidence map›Paper›PMID 36747758›Full record

ArticlebioRxiv : the preprint server for biology2023

Fructose Induced KHK-C Increases ER Stress and Modulates Hepatic Transcriptome to Drive Liver Disease in Diet-Induced and Genetic Models of NAFLD.

Se-Hyung Park, Robert N Helsley, Taghreed Fadhul, Jennifer L S Willoughby, Leila Noetzli, Ho-Chou Tu, Marie H Solheim, Shiho Fujisaka, Hui Pan, Jonathan M Dreyfuss and 13 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 3 countries.

Se-Hyung ParkDepartment of Pediatrics, Division of Pediatric Gastroenterology, University of Kentucky College of Medicine, Lexington, KY. 40536.
Robert N HelsleyDepartment of Pediatrics, Division of Pediatric Gastroenterology, University of Kentucky College of Medicine, Lexington, KY. 40536.
Taghreed FadhulDepartment of Pediatrics, Division of Pediatric Gastroenterology, University of Kentucky College of Medicine, Lexington, KY. 40536.
Jennifer L S WilloughbyAlnylam Pharmaceuticals Inc., Cambridge, MA. 02142.
Leila NoetzliAlnylam Pharmaceuticals Inc., Cambridge, MA. 02142.
Ho-Chou TuAlnylam Pharmaceuticals Inc., Cambridge, MA. 02142.
Marie H SolheimSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA. 02215.
Shiho FujisakaSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA. 02215.
Hui PanBioinformatics and Biostatistics Core, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Jonathan M DreyfussBioinformatics and Biostatistics Core, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Joanna BonsProteomics and Aging Center, Buck Institute for Research on Aging, Novato, CA 94945.
Jacob RoseProteomics and Aging Center, Buck Institute for Research on Aging, Novato, CA 94945.
Christina D KingProteomics and Aging Center, Buck Institute for Research on Aging, Novato, CA 94945.
Birgit SchillingProteomics and Aging Center, Buck Institute for Research on Aging, Novato, CA 94945.
Aldons J LusisDepartment of Medicine/Division of Cardiology, Department of Human Genetics, A2-237 Center for the Health Sciences, University of California, Los Angeles, Los Angeles, CA USA.
Calvin PanDepartment of Medicine/Division of Cardiology, Department of Human Genetics, A2-237 Center for the Health Sciences, University of California, Los Angeles, Los Angeles, CA USA.
Manoj GuptaSection of Islet Cell and Regenerative Biology, Joslin Diabetes Center; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02215.
Rohit N KulkarniSection of Islet Cell and Regenerative Biology, Joslin Diabetes Center; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02215.
Kevin FitzgeraldAlnylam Pharmaceuticals Inc., Cambridge, MA. 02142.
Philip A KernDepartment of Medicine, Division of Endocrinology, University of Kentucky College of Medicine, Lexington, KY. 40536.
Senad DivanovicDepartment of Pediatrics, University of Cincinnati College of Medicine, Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
C Ronald KahnSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA. 02215.
Samir SofticDepartment of Pediatrics, Division of Pediatric Gastroenterology, University of Kentucky College of Medicine, Lexington, KY. 40536.
Joslin Diabetes Center · USAlnylam Pharmaceuticals (United States) · USBuck Institute for Research on Aging · USUniversity of Kentucky · USUniversity of California, Los Angeles · USCincinnati Children's Hospital Medical Center · US

Funding

Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Role of IGF-1 and Insulin Receptors Beta-Cell SurvivalR01DK067536 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 2004 to 2026
$8.0M
Pilot Projects ProgramP30GM127211 · NIGMS · UNIVERSITY OF KENTUCKY · PI CASSIS, LISA A · 2018 to 2022
$5.7M
Immunopathogenesis of Non-alcoholic Fatty Liver DiseaseR01DK099222 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Senad Divanovic · 2013 to 2026
$5.6M
Systems Genetics Dissection of Non-alcoholic SteatohepatitisR01DK117850 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Aldons Jake Lusis · 2019 to 2026
$4.6M
Systems genetics approach to inflammatory mechanisms in atherosclerosisR01HL147883 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LUSIS, ALDONS JAKE · 2019 to 2022
$3.0M
Orbitrap Fusion Lumos ETD with FAIMS ProS10OD028654 · OD · BUCK INSTITUTE FOR RESEARCH ON AGING · PI SCHILLING, BIRGIT · 2020 to 2020
$1.1M
Elucidating Molecular Mechanisms Linking Fructose to Cholesterol MetabolismK01DK128022 · NIDDK · UNIVERSITY OF KENTUCKY · PI Robert Nathaniel Helsley · 2022 to 2026
$647k
NCATS NIH HHS UL1 TR001998NHLBI NIH HHS R01 HL147883NICHD NIH HHS K12 HD000850NIDDK NIH HHS K01 DK128022NIDDK NIH HHS R01 DK067536NIDDK NIH HHS R01 DK099222NIDDK NIH HHS R01 DK117850NIGMS NIH HHS P30 GM127211NIH HHS S10 OD028654
6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome, and is estimated to affect one billion individuals worldwide. An increased intake of a high-fat diet (HFD) and sugar-sweetened beverages are risk-factors for NAFLD development, but how their combined intake promotes progression to a more severe form of liver injury is unknown. Here we show that fructose metabolism via ketohexokinase (KHK) C isoform increases endoplasmic reticulum (ER) stress in a dose dependent fashion, so when fructose is coupled with a HFD intake it leads to unresolved ER stress. Conversely, a liver-specific knockdown of KHK in C57BL/6J male mice consuming fructose on a HFD is adequate to improve the NAFLD activity score and exert a profound effect on the hepatic transcriptome. Overexpression of KHK-C in cultured hepatocytes is sufficient to induce ER stress in fructose free media. Upregulation of KHK-C is also observed in genetically obesity ob/ob, db/db and lipodystrophic FIRKO male mice, whereas KHK knockdown in these mice improves metabolic function. Additionally, in over 100 inbred strains of male or female mice hepatic KHK expression correlates positively with adiposity, insulin resistance, and liver triglycerides. Similarly, in 241 human subjects and their controls, hepatic

Identifiers

PMID36747758
PMCPMC9900898
OpenAlexW4318303150

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.